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A major factor in the progression to heart failure in humans is the inability of the adult 
heart to repair itself after injury. We recently demonstrated that the early postnatal 
mammalian heart is capable of regeneration following injury through proliferation of 
preexisting cardiomyocytes1,2 and that Meis1, a three amino acid loop extension (TALE) 
family homeodomain transcription factor, translocates to cardiomyocyte nuclei shortly 
after birth and mediates postnatal cell cycle arrest3. Here we report that Hoxb13 acts as a 
cofactor of Meis1 in postnatal cardiomyocytes. Cardiomyocyte-specific deletion of Hoxb13 
can extend the postnatal window of cardiomyocyte proliferation and reactivate the 
cardiomyocyte cell cycle in the adult heart. Moreover, adult Meis1–Hoxb13 double-
knockout hearts display widespread cardiomyocyte mitosis, sarcomere disassembly and 
improved left ventricular systolic function following myocardial infarction, as 
demonstrated by echocardiography and magnetic resonance imaging. Chromatin 
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immunoprecipitation with sequencing demonstrates that Meis1 and Hoxb13 act 
cooperatively to regulate cardiomyocyte maturation and cell cycle. Finally, we show that 
the calcium-activated protein phosphatase calcineurin dephosphorylates Hoxb13 at serine-
204, resulting in its nuclear localization and cell cycle arrest. These results demonstrate 
that Meis1 and Hoxb13 act cooperatively to regulate cardiomyocyte maturation and 
proliferation and provide mechanistic insights into the link between hyperplastic and 
hypertrophic growth of cardiomyocytes. 
Heart failure affects more than 26 million people worldwide1, and thus finding effective 
therapies for heart failure is a major public health goal. A key underlying cause of heart failure is 
the inability of the adult human myocardium to regenerate following injury. Although both adult 
mouse2,3 and human4 hearts have a limited capacity for cardiomyocyte turnover5, this low basal 
rate of cardiomyogenesis is not therapeutically relevant from a regeneration perspective. By 
contrast, newborn mammals are capable of myocardial regeneration for a short time after birth, 
mediated by proliferation of preexisting cardiomyocytes6,7. Several regulators of postnatal 
cardiomyocyte cell cycle arrest have been described thus far8–13, highlighting the complexity of 
cardiomyocyte cell cycle regulation and the need for better understanding of the interplay 
between these redundant mechanisms. 
Meis1, a homeobox transcription factor belonging to the TALE family, was identified as 
a regulator of the cardiomyocyte cell cycle3[Author: Inserted citation. OK? No please, it should 
be ref # 9, not #3, which is added in the following sentence]. Deletion of Meis1 prolongs the 
postnatal window of myocyte proliferation, and reactivates cardiomyocyte mitosis in adult 
mouse heart. However, cardiomyocyte proliferation following Meis1 deletion is transient, and 
cell cycle arrest eventually ensues9. Indeed, although conditional deletion of Meis1 prevented 
continued deterioration of left ventricular function following proximal left anterior descending 
coronary artery (LAD) ligation, there was minimal improvement in function compared with 
immediately after myocardial infarction (MI) values (Extended Data Fig. 1a). Therefore, it is 
plausible that other additional redundant mechanisms are activated following Meis1 deletion. 
Meis1 is known to associate with a number of proteins that regulate its cellular localization and 
transcriptional activity14–16; however, their role in cardiomyocytes remains unknown. We set out 
to identify regulators of Meis1 expression and function in the postnatal heart and to define their 
role in regulation of cardiomyocyte cell cycle. 
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Hoxb13 associates with Meis1 postnatally 
Among the Hox family of transcription factors that are upregulated in the early postnatal 
window9, Hoxb13 was the only one with an expression pattern similar to that of Meis1 (Fig. 1a, 
b, Extended Data Fig. 1b, c). Hoxb13 localized to cardiomyocyte nuclei at the time of cell cycle 
arrest on postnatal day (P)7, and Hoxb13 levels were low in P7 hearts that had been subjected to 
LAD ligation at P1, a procedure that induces cardiomyocyte proliferation seven days after injury; 
Hoxb13 levels increased as the mouse heart switched from hyperplastic (P1) to hypertrophic 
growth (P7). Moreover, coimmunoprecipitation and proximity ligation assays (PLA) revealed the 
association of Hoxb13 and Meis1 at P7 (Fig. 1c–e, Extended Data Fig. 1d–g). 
Genetic deletion of Hoxb13 
As previously noted, Hoxb13 might have similar a role as Meis1 in postnatal cardiomyocyte 
proliferation. We therefore generated a conditional cardiomyocyte-specific Myh6cre:Hoxb13fl/fl 
(hereafter, Hoxb13-KO) mice (Extended Data Fig. 1h, i). Western blot analysis revealed a 
reduction of Hoxb13 protein in Hoxb13-KO hearts (Extended Data Fig. 1j, left). Meis1 was 
cytoplasmic in cardiomyocytes of Hoxb13-KO hearts at P14, although Meis1 was localized to 
the nucleus in non-cardiomyocyte cells[Author: OK?] and in wild-type cardiomyocytes 
(Extended Data Fig. 1k). Compared with wild-type hearts, despite the absence of differences in 
cardiac morphology, heart weight to body weight ratio (Fig. 1f) and left ventricle (LV) function 
(Extended Data Fig. 1l), we observed a significant reduction in individual cardiomyocyte cross-
sectional area (CSA) (Fig. 1g) and an increase of pH3-positive mitotic cardiomyocytes (pH3+) 
(Fig. 1h) in Hoxb13-KO hearts at P14, but not in older hearts (data not shown). Thus, 
prolongation of the postnatal window of cardiomyocyte proliferation secondary to Hoxb13 
deletion is not sustained, similar to the phenotype resulting from Meis1 deletion. To test whether 
Hoxb13 deletion is sufficient to induce postmitotic cardiomyocyte cycle re-entry, we generated a 
tamoxifen-inducible cardiomyocyte-specific Myh6mERcremERHoxb13fl/fl mouse (hereafter, Hoxb13-
iKO). Hoxb13 protein reduction in adult heart was confirmed by western blot two weeks after 
tamoxifen injection (Extended Data Fig. 1j, right). Cardiac morphology, heart weight/body 
weight (Fig. 1i), and fibrosis (Extended Data Fig. 1m) were unaltered in the Hoxb13-iKO hearts. 
However, cardiomyocyte CSA was significantly reduced in the Hoxb13-iKO hearts (Fig. 1j). 
There was also a marked increase in pH3+ (Fig. 1k), and aurora B kinase-positive 
cardiomyocytes (Fig. 1l). Quantification of adult cardiomyocyte number following collagenase 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 MS nr: 2018-11-17051D 
Page 4 of 36 
digestion showed a significant increase in the number of cardiomyocytes in the Hoxb13-iKO 
hearts (Fig. 1m). There was also a significant increase in the fraction of mononucleated 
cardiomyocytes and a decrease in multinucleated cardiomyocytes (Fig. 1n). In addition, we used 
a lineage-tracing system in which we crossed cardiomyocyte-specific Myh6mERcremER and mosaic 
analysis with double markers (MADM) mice17 with the Hoxb13fl/fl mice to examine 
cardiomyocyte division. Assessment of single-coloured green or red cardiomyocytes confirmed 
that Hoxb13 deletion resulted in more than twofold induction of new cardiomyocyte formation 
(Fig. 1o). Finally, there were no significant changes in cell death, as measured using TUNEL 
assay (Extended Data Fig. 1n). The evidence thus far suggested that cardiomyocyte-specific 
deletion of Hoxb13 is sufficient to induce measurable cardiomyocyte mitosis in adult hearts. 
To determine whether Hoxb13 deletion leads to meaningful cardiomyocyte regeneration, 
we induced MI in adult Hoxb13-KO mice (Extended Data Fig. 2a). Although the initial reduction 
in left-ventricle ejection fraction (LVEF) was comparable between two groups at one week after 
MI (Fig. 1.p), serial echocardiographic assessment revealed a progressive deterioration of LVEF 
in the controls, but not in Hoxb13-KO mice, such that at 8 to 16 weeks after the MI, the Hoxb13-
KO hearts had significantly higher LVEF compared to controls (Fig. 1p, Extended Data Fig. 2b). 
There was no significant difference in heart weight/body weight, wet-to-dry lung ratio or scar 
formation (Extended Data Fig. 2c–e). Similarly, inducible knockout of Hoxb13 in adult mice also 
prevented the progressive decline in LVEF (Extended Data Fig. 2f–i). However, there was no 
improvement in left-ventricle systolic function in the myocardial-infarct hearts following 
deletion of Hoxb13 over time, compared with immediate post-injury values. Together, these 
findings suggest that loss of Hoxb13 prevents progressive deterioration of systolic function 
following MI, but does not induce substantial functional recovery. This may be owing to the 
transient nature of activation of cardiomyocyte mitosis following Hoxb13 deletion. 
Combined loss of Meis1 and Hoxb13 
Next we generated cardiomyocyte-specific Myh6cre:Meis1-Hoxb13 double-knockout mice 
(hereafter, DKO) to examine cardiomyocyte proliferation at P28. The Meis1-KO and Hoxb13-
KO mice do not show significant cardiomyocyte division at this time point. We observed a 
modest but significant decrease in heart weight/body weight (Extended Data Fig. 3a) in DKO 
mice, despite a significant decrease in cardiomyocyte CSA in the DKO hearts compared with 
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wild-type hearts (Extended Data Fig. 3b). Of note, there was a marked increase in pH3+ and 
aurora B kinase-positive cardiomyocytes in the DKO hearts (Extended Data Fig. 3c, d), and 
some cardiomyocytes displayed sarcomere disassembly (Extended Data Fig. 3c), which is 
characterized by loss of striations and localization of the sarcomeres to the periphery of 
cardiomyocytes. This is a hallmark of cardiomyocyte proliferation in neonatal hearts and is 
seldom seen in the adult heart, even when mitotic indices are present. In support of the increased 
mitosis, the total cardiomyocyte number in DKO hearts was significantly greater than in 
controls, with an associated increase in mononucleated cardiomyocytes and a decline in 
binucleated and multinucleated cardiomyocytes (Extended Data Fig. 3e, f). Cardiac morphology 
and function (Extended Data Fig. 3a, g) revealed no differences between DKO and control mice. 
Cardiomyocyte proliferation remained active in six-month-old DKO hearts (Extended Data Fig. 
3h, i). Although the cardiomyocyte CSA in the six-month-old DKO mice was still significantly 
smaller, the LVEF remained similar to that of controls (Extended Data Fig. 3j, k). 
Given that DKO hearts consistently displayed a smaller cell size, we performed further 
studies to assess the effect of deletion of Meis1 and Hoxb13 on the cardiomyocyte hypertrophy. 
We detected a blunted response to pathological hypertrophy following pressure overload induced 
by transverse aortic constriction (TAC) in DKO hearts, in which DKO hearts had better LVEF, 
and smaller absolute heart weight, heart weight/body weight, heart weight/tibia length and 
cardiomyocyte CSA than controls at three weeks after TAC (Extended Data Fig. 4a–h). There 
was no difference in tibia length and myocardial interstitial fibrosis (Extended Data Fig. 4d, g). 
In addition, the DKO hearts exhibited an attenuated exercise-induced physiological hypertrophic 
response (Extended Data Fig. 4i–p). 
Heart regeneration in the DKO 
We next examined whether conditional inducible deletion of Meis1 and Hoxb13 in the adult 
heart (DiKO) could promote cardiomyocyte cell cycle re-entry. Inducible deletion of both genes 
did not alter cardiac morphology or fibrosis (Fig. 2a, Extended Data Fig. 5a). Notably, however, 
heart weight/body weight increased (Fig. 2b); the DiKOs also showed diminished cardiomyocyte 
CSA by about 30% one week after tamoxifen injection (Fig. 2c). There was also a significant 
increase in the number of ventricular cardiomyocytes with disassembled sarcomeres at this time 
point (Fig. 2d, Extended Data Fig. 5b, c). Because sarcomere disassembly is an unusual event in 
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adult hearts, we examined cardiomyocyte death and found a significant increase in TUNEL+ 
cardiomyocytes one week after deletion, but not at a later time point (two months after deletion) 
(Fig. 2e, Extended Data Fig. 5d). Of note, the numbers of cardiomyocytes undergoing mitosis 
and cytokinesis were also markedly increased in DiKO hearts one week after deletion. However, 
the number of mitotic cardiomyocytes in DiKO mice decreased by two months after deletion 
compared with one week after deletion (Fig. 2f, Extended Data Fig.e–h). Assessment of DiKO-
MADM mice showed over a threefold increase in single-coloured green or red cardiomyocytes 
(Fig. 2g). Consistently, 5-bromodeoxyuridine (BrdU) staining, coupled with cardiomyocyte 
nuclear staining using PCM-1 revealed labelling of approximately 7% of cardiomyocyte nuclei 
in the DiKO hearts two weeks after deletion (Fig. 2h). Finally, we observed a significant increase 
in the total number of cardiomyocytes in the DiKO hearts (Fig. 2i), with an increase in the 
number of mononucleated cardiomyocytes (Fig. 2j). Together, these results demonstrate that 
concomitant cardiomyocyte-specific loss of Meis1 and Hoxb13 induces proliferation of adult 
ventricular cardiomyocytes. 
To test whether the increase in aforementioned cardiomyocyte proliferation can 
contribute to consequential cardiac repair in the adult heart, we first examined the expression of 
cell cycle inhibitors two weeks after MI by western blotting, revealing a post-MI decrease in p21 
and p15/16 proteins in the DKO hearts (Extended Data Fig. 6a–c). Next, we subjected DiKO 
mice to MI one week before gene deletion (Fig. 2k). The results revealed that the infarcted DiKO 
hearts had smaller fibrotic scars, and lower heart weight/body weight and absolute heart weight 
values 16 weeks after MI compared with controls, although their body weight was comparable 
(Fig. 2l, Extended Data Fig. 6d–f). None of the DiKO mice displayed left atrial dilatation 
(Extended Data Fig. 6g). Although both groups showed a similar reduction in LVEF one week 
after MI, starting from week 4, the DiKO mice displayed a gradual and significant improvement 
in LVEF (Fig. 2m, n). DiKO mice also showed a marked increase in the infarcted anterior wall 
thickness and a significant decrease in ventricular dilation (Extended Data Fig. 6k–q). Consistent 
with these results, magnetic resonance imaging (MRI) at 16 weeks after MI showed a significant 
increase in LVEF[Author: LVEF OK? It was EF originally.Yes, thanks], stroke volume and 
cardiac output indexes (Fig. 2o–q, Extended Data Fig. 6i), with a similar heart rate (Extended 
Data Fig. 6j), in the DiKO mice compared with controls. In addition, the wet-to-dry lung weight 
ratio in the DiKO was smaller than in the control group, indicating prevention of pulmonary 
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edema (Fig. 2r). These results suggest that the induction of cardiomyocyte proliferation 
following loss of both Meis1 and Hoxb13 can improve LV systolic function following MI. 
Next, we used chromatin immunoprecipitation with next-generation sequencing (ChIP–
seq) to identify the in vivo targets of Meis1 and Hoxb13. Three distinct sets of genes were 
identified: 272 genes that are targets for both Meis1 and Hoxb13, 1,647 genes that are targets for 
Meis1 only and 1,326 genes that are targets Hoxb13 only (Extended Data Fig. 7). Pathway 
analysis suggested that Meis1 and Hoxb13 synergistically regulate cardiomyocyte differentiation 
and cell cycle. 
Calcineurin (CN) regulates Hoxb13 
Concurrent with the postnatal loss of proliferative capacity, cardiomyocytes switch to 
hypertrophic growth. Calcineurin-dependent signalling is known to be a fundamental mediator of 
hypertrophic growth. Therefore, we examined postnatal changes in calcineurin abundance. 
Western blotting showed an increase in protein levels of the catalytic subunit of calcineurin 
(CnA) at P7, similar to Meis1 and Hoxb13 (Fig. 3a). Coimmunoprecipitation using CnA, Meis1 
and Hoxb13 antibodies revealed that these three proteins interact in the postnatal heart (Fig. 3b–
d, Extended Data Fig. 8a–c). Notably, although PLA confirmed the association of CnA with both 
Meis1 and Hoxb13, the frequency and intensity of the foci for Hoxb13–CnA was higher than for 
Meis1–CnA (Fig. 3e, Extended Data Fig. 8d–f). We next examined whether Meis1 and Hoxb13 
are direct targets of calcineurin by scanning for calcineurin-docking motifs. A sequence in 
Hoxb13, ITIWFQ (amino acids 262–267) was identified as a potential PxIxIT site that, similar to 
the motif in AKAP79, contains an isoleucine in the first position18 (Extended Data Fig. 8h). To 
determine whether CnA interacts with this sequence in Hoxb13, we performed an in vitro pull-
down assay for CnA–His6 with GST fused to a 16-amino-acid peptide containing either the 
ITIWFQ sequence, or a mutant peptide containing alanine substitutions in this putative motif 
(Fig. 3f). The results showed that CnA co-purified with the GST–Hoxb13 peptide, but not the 
mutated form, indicating a PxIxIT-mediated interaction (Fig. 3g), suggesting that Hoxb13 
directly interacts with, and may be dephosphorylated by, calcineurin. 
Hoxb13 immunostaining in hearts with cardiomyocyte-specific expression of either a 
constitutively active transgene of Ppp3ca[Author: We always include the official gene symbol at 
first mention.] (the gene encoding CnA) (CnA-Tg), or Rcan1[Author: Changed to initial upper 
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case only, as presumably it is a mouse gene.], an endogenous inhibitor of calcineurin (Rcan1-
Tg), showed that Hoxb13 was prematurely localized to nuclei in CnA-Tg hearts at P2 (Fig. 3h). 
In contrast to wild-type hearts, which show a strong nuclear Hoxb13 signal at P7, Rcan1-Tg 
hearts at P7 showed only a faint Hoxb13 signal (Fig. 3i). We hypothesized that calcineurin-
mediated dephosphorylation controls nuclear localization of Meis1 and Hoxb13. We generated 
custom polyclonal phospho-specific antibodies against four predicted sites in Hoxb13 and six 
sites in Meis1 (Extended Data Fig. 8g, h) and used them to compare the Meis1 and Hoxb13 
phosphorylation status in postnatal hearts. We found that only the antibody directed against 
Hoxb13 S204 detected a band that was more intense at P1 than at P7 (Fig. 3j, Extended Data Fig. 
8i, j). None of the Meis1 phospho-specific antibodies showed evidence of differential 
phosphorylation (Extended Data Fig. 8k). Of note, Hoxb13 S204 phosphorylation was decreased 
in the CnA-Tg P2 hearts (a time point when S204-phosphorylation can be detected in the wild-
type)[Author: Please specify which time point you mean here. It is P2]. Conversely, the Rcan1-
Tg P2 hearts showed an increase in S204 phosphorylation (Fig. 3m, n). Thus, this previously 
unidentified phosphorylation site at S204 in Hoxb13 appears to be dephosphorylated by 
calcineurin in the postnatal heart at the time of cardiomyocyte cell cycle arrest. 
To better understand the effect of S204 phosphorylation on Hoxb13, we constructed 
plasmids expressing wild-type and mutant GFP–Hoxb13 fusion proteins and examined their 
spatial expression in primary cultured DKO cardiac fibroblasts (Fig. 3o, Extended Data Fig. 8l). 
Transient transfection with wild-type Hoxb13 or dephosphorylation-mimetic Hoxb13(S204A) 
constructs resulted in nuclear localization of GFP–Hoxb13, whereas the phospho-mimetic 
Hoxb13 constructs (Hoxb13(S204D) and Hoxb13(S204E)) completely eliminated Hoxb13–GFP 
nuclear localization (Fig. 3p). These results suggest that calcineurin-dependent 
dephosphorylation of Hoxb13 at S204 promotes nuclear translocation of Hoxb13 and facilitates 
cell cycle arrest. 
CN regulates cardiomyocyte proliferation 
Previous reports indicate that CnA overexpression in cardiomyocytes results in profound 
pathological hypertrophy19. Consistently, we observed an increase in heart weight/body weight 
and cardiomyocyte CSA as early as P2 and subsequently, at P21 (Fig. 4a, b, Extended Data Fig. 
9a–d). In addition, CnA-Tg hearts contained significantly fewer pH3+ cardiomyocytes at P2 (Fig. 
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4c, Extended Data Fig. 9e). Conversely, in Rcan1-Tg hearts, there were more pH3+ 
cardiomyocytes compared to wild-type at P21 (Fig. 4d, Extended Data Fig. 9f). This suggests 
that forced expression of activated calcineurin causes a premature switch from hyperplasic 
growth to hypertrophic growth, whereas inhibition of calcineurin prolongs the window of 
cardiomyocyte proliferation. 
Next, we examined the regenerative capacity of CnA-Tg hearts following apical resection 
at P1 (Extended Data Fig. 9g). Twenty-one days after resection, CnA-Tg hearts displayed a 
significantly reduced LVEF (Fig. 4e) with prominent scars (Fig. 4f, g) compared with controls. 
Moreover, similar to wild-type hearts, CnA-Tg/Rcan1-Tg double-transgenic hearts recovered 
fully by P21. Consistently, Rcan1-overexpression-inhibited CnA activity enhanced 
cardiomyocyte proliferation at one week after MI (Fig. 4h, i), and improved LVEF[Author: 
Originally EF. OK?OK] over two months compared with wild-type mice. Although 
LVEF[Author: Originally EF. OK?OK] of the Rcan1-Tg mice showed a trend towards 
improvement compared to post-MI values, this did not reach statistical significance (Fig. 4j). 
In this study, we identify Hoxb13 as a Meis1 cofactor in postnatal cardiomyocytes. 
Whereas Hoxb13 deletion resulted in transient induction of cardiomyocyte proliferation, loss of 
both Hoxb13 and Meis1 resulted in blunting of both physiological and pathological hypertrophic 
growth, and a robust and sustained induction of cardiomyocyte mitosis. The morphological 
changes in some DKO cardiomyocytes are reminiscent of neonatal cardiomyocytes, with 
sarcomere disassembly and localization of sarcomeres to the cellular cortex. We also report 
robust improvement in LVEF when Meis1 and Hoxb13 are conditionally deleted following 
injury. This is supported by results of ChIP–seq, which demonstrate that the targets of Meis1 and 
Hoxb13 in the mouse heart include a diverse set of pathways involved in cardiomyocyte 
proliferation, differentiation and sarcomere organization, in addition to genes involved in 
regulation of cardiomyocyte hypertrophy. 
We further show how suppression of hyperplastic growth by Hoxb13–Meis1 is integrated 
with activation of hypertrophic growth through calcineurin-dependent signalling. The 
mammalian heart undergoes substantial circulatory remodelling after birth, resulting in structural 
and pressure changes that result in a significant and persistent increase in pressure load on the 
LV20. This increase in load coincides with cell cycle withdrawal of cardiomyocytes, and is 
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associated with activation of a number of pathways that mediate the postnatal hypertrophic 
growth. In particular, the phosphatase calcineurin is thought to have a critical role in induction of 
cardiomyocyte hypertrophy in response to load; however, whether it simultaneously has a role in 
suppressing cell cycle progression—thereby coordinating the switch from hyperplastic to 
hypertrophic cardiac growth—is not known. 
Calcineurin is a Ca2+–calmodulin-activated phosphatase which has been extensively 
studied because of its role in a wide array of biological functions, including cardiac 
hypertrophy19,21–24. Calcineurin-dependent hypertrophic growth occurs when there is a sufficient 
rise in diastolic Ca2+ levels, can occur on a broad array of substrates, and mediates diverse 
signalling cascades25. Relative to cardiac hypertrophy, many studies have focused on the ability 
of calcineurin to activate transcription via the nuclear factor of activated T cell (NFAT) family of 
transcription factors19,26,27. Although most studies have focused on the role of calcineurin in 
pathological hypertrophic remodelling, there is substantial evidence that it is involved in normal 
postnatal cardiac growth as well as physiological hypertrophy28,29. Our results demonstrating that 
Meis1 and Hoxb13 are involved in the induction of both pathological and physiological 
cardiomyocyte hypertrophy as well as the cardiomyocyte cell cycle downstream of calcineurin 
highlight the complex role of calcineurin in cardiomyocyte maturation in the postnatal heart. 
We provide several lines of evidence that support the role of calcineurin in postnatal cell 
cycle arrest of cardiomyocytes through its regulation of Hoxb13. First, we show that calcineurin 
associates with Hoxb13 in postnatal cardiomyocytes at the time of cell cycle arrest. Second, we 
identify a calcineurin PxIxIT site in Hoxb13, which mediates binding of Hoxb13 to calcineurin. 
Third, we show that calcineurin gain and loss of function in cardiomyocytes regulates nuclear 
localization of Hoxb13. Fourth, we show that Hoxb13 S204, which is dephosphorylated at P7 
compared with P1 in the postnatal heart, is differentially dephosphorylated by calcineurin gain 
and loss of function, and regulates nuclear localization of Hoxb13. Finally, we show that gain 
and loss of function of calcineurin regulates postnatal cardiomyocyte proliferation and heart 
regeneration. 
In summary, our results indicate that flux through calcineurin signalling provides a 
coordinating link between the postnatal increase in cardiac load and suppression of the 
regenerative capacity of the mammalian heart, and identifies Hoxb13 as an important regulator 
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of cardiomyocyte differentiation and proliferation. The Meis1 Hoxb13 DKO cardiomyocyte 
mitosis phenotype outlined in this study indicates that reversion to a more immature state of 
cardiomyocytes is feasible, and suggests that this pathway might be a viable target for 
therapeutic interventions. Overall, these findings support the notion that adaptation to 
environmental cues of postnatal life is an important determinant of postnatal cardiomyocyte cell 
cycle arrest. 
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Fig. 1 | Identification of Hoxb13 as a Meis1-interacting transcription factor in postnatal 
cardiomyocytes. a, Immunostaining of Hoxb13 (red), sarcomeric-α-actinin (green) and nucleus 
(blue) at P1, P7 and seven days after P1 MI. The inset shows a higher magnification of the 
outlined region. b, Western blot analysis of Meis1 and Hoxb13 proteins during regenerative 
stages. c, d, Coimmunoprecipitation using Meis1 (c) and Hoxb13 (d) antibodies from total heart 
extracts at P1 and P7. e, PLA of Meis1–Hoxb13 (red dots) in P7 heart. f, Haematoxylin and 
eosin (H&E)-stained heart sections and heart weight/body weight in Hoxb13-KO mice at P14. g, 
Wheat germ agglutinin (WGA) staining and CSA quantification in Hoxb13-KO hearts. h, 
Immunostaining for pH3 (green) and cardiac troponin T (cTnT, red) showing the percentage of 
mitotic cardiomyocytes (arrowheads). i–n, Quantification of Hoxb13-iKO hearts at 14 days after 
deletion. i, Heart weight/body weight and H&E-stained heart sections. j, WGA staining and CSA 
quantification. k, l, Immunostaining for pH3 or aurora B kinase (AurkB) (green), cardiac 
troponin T (red) and nucleus (blue), showing the percentage of mitotic (k) and cytokinetic (l) 
cardiomyocytes. m, n, Total number (m) and nucleation (n) of isolated cardiomyocytes. o, 
Representative immunofluorescence and quantification of single-labelled (red or green, 
arrowheads) cardiomyocytes in Hoxb13-iKO-MADM mice. p, Serial echocardiographic 
measurement of control and Hoxb13-KO MI mice. Data are mean ± s.e.m.; unpaired two-sided t-
test. Data in a–e were independently repeated three times with similar results. *P < 0.05, 
**P < 0.01, ***P < 0.001. For gel source data, see Supplementary Fig. 1. For sample numbers, 
see Methods. Scale bars: 10 μm (a, g, h, k, l, n), 50 μm (e, j, o), 1 mm (f, i). See also Extended 
Data Figs. 1, 2. 
Fig. 2 | Loss of Meis1 and Hoxb13 induces cardiomyocyte proliferation and heart 
regeneration. a, Representative H&E-stained heart sections four weeks after inducible deletion 
of Meis1 and Hoxb13 (DiKO). b–d, Heart weight/body weight (b), WGA staining and CSA 
quantification (c), and representative image of sarcomere disassembly and quantification in 
DiKO hearts at one week after deletion (d). WGA (green), cardiac troponin T (red) and nucleus 
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(blue). e, Quantification of TUNEL+ cardiomyocytes in DiKO hearts at one week and two 
months after deletion. f, Immunostaining for pH3 (green) and cardiac troponin T (red) showing 
the percentage of mitotic cardiomyocytes. g, Representative immunofluorescence images and 
quantification of single-labelled (red or green, arrows) cardiomyocytes in DiKO-MADM mice. 
h, Representative images and quantification of proliferating cardiomyocytes (PCM+BrdU+ cells, 
arrows) from BrdU pulse-chase experiments from cryosections of an entire heart. The smaller 
panels show selected regions at higher magnification.[Author: Can you provide scale bars for 
these images in h?] i, j, Total number of cardiomyocytes (i) and nucleation quantification (j) in 
DiKO hearts. k, Schematic of MI model in DiKO mice. l, m, Representative serial Masson’s 
trichrome-stained transverse sections and quantification of fibrotic scars (l), and representative 
echocardiography of control and DiKO MI mice at 16 weeks after injury (m). n, Serial 
echocardiographic measurement of control and DiKO MI mice. o, p, q, Representative images of 
MRI (o), LVEF[Author: Is this LVEF? If so, probably best to use the same term throughout once 
it is defined. Yes] (p) and stroke volume index (q)[Author: In o, (1) are there two different 
samples? They are not labelled in the figure. Sorry, I have added the name of samples. (2) Can 
you provide a scale bar?]. r, Wet-to-dry lung weight ratio in DiKO mice 16 weeks after MI. Data 
are mean ± s.e.m.; unpaired two-sided t-test. *P < 0.05, **P < 0.01, ***P < 0.001. For sample 
numbers, see Methods. Scale bars: 10 μm (d, f, g, h), 50 μm (c), 1 mm (a, l, o). See also 
Extended Data Figs. 3–6. 
Fig. 3 | Calcineurin regulates Hoxb13 expression in the postnatal hearts. a, Western blot 
analysis of Meis1, Hoxb13 and CnA proteins during regenerative stages. b–d, 
Coimmunoprecipitation of CnA (b), Meis1 (c) and Hoxb13 (d) from total heart lysates at P1 and 
P7. e, PLA showing Hoxb13–calcineurin (red dots) in P7 heart. f, Schematic of Hoxb13 mutant 
at the predicated PxIxIT site. g, Quantitative pull-down assay with purified recombinant His6-
tagged CnA and GST-tagged Hoxb13 peptide or mutant peptides. Dig2–GST serves as positive 
control. h, i, Top, merged images of immunostaining for Hoxb13 (red, arrow, bottom) and 
sarcomeric α-actinin (green) showing the subcellular localization of Hoxb13 in P2 CnA-Tg (h) or 
P7 Rcan1-Tg (i) hearts. DAPI (blue) indicates nucleus. j, Western blot analysis of 
phosphorylated Hoxb13 proteins during regenerative stages. m, n, Western blot analysis of 
phosphorylated Hoxb13S204 in CnA-Tg and Rcan1-Tg P2 hearts (m) and densitometry 
quantification (n). Rcan1.4[Author: Should this be Rcan1 and not Rcan1.4? If not, please clarify 
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the difference. It is Rcan 1.4, a smaller isoform of Rcan1 but can also be detected using Rcan 
antibody] (26 kDa) indicates CnA-Tg heart; truncated Rcan1.4 (13 kDa) indicates Rcan1-Tg 
heart. GAPDH serves as loading controls (a, j, m). o, Schematic showing generation of primary 
cardiac DKO fibroblasts for assessing S204 phosphorylation-dependent nuclear localization of 
Hoxb13. p, Representative images of subcellular localization of Hoxb13–GFP mutants in cardiac 
DKO fibroblasts. Data are mean ± s.e.m.; unpaired two-sided t-test. Data in a–e, g, j, p were 
independently repeated three to six times with similar results. *P < 0.05, **P < 0.01, 
***P < 0.001. For gel source data, see Supplementary Fig. 1. For sample numbers, see Methods. 
Scale bars: 50 μm (e, h, i, p). See also Extended Data Fig. 8. 
Fig. 4 | Increased calcineurin activity suppresses postnatal cardiomyocyte proliferation. a, 
b, CSA quantification in wild-type and CnA-Tg in P2 (a) and P21 hearts (b). c, d, Percentage of 
mitotic cardiomyocytes in CnA-Tg P2 (c) or Rcan1-Tg P21 (d) hearts. e, Echocardiographic 
measurement of cardiac function 21 days after resection. f, g, Representative Masson’s trichrome 
staining (f; scale bars, 1 mm) and scar area quantification (g) of apical resected hearts 21 days 
after resection. h, Schematic of MI model in Rcan1-Tg mice. i, Quantification of pH3+ 
cardiomyocytes in wild-type and Rcan1-Tg heart sections one week after MI induction. j, Serial 
echocardiographic measurement of wild-type and Rcan1-Tg MI mice. Data are mean ± s.e.m.; 
unpaired two-sided t-test. *P < 0.05, **P < 0.01, ***P < 0.001. For sample numbers, see 
Methods. See also Extended Data Fig. 9. 
[Author: Please ensure that the following information is provided in the Methods section where 
relevant. Animal experiments require: statement about randomization; statement about blinding; 
statement of sex, age, species and strain of animals; statement of IRB approval for live vertebrate 
experimentation. For experiments involving humans: statement of IRB approval; statement of 
informed consent; statement of consent to publish any photos included in figures. Randomized 
clinical trials require trial registration. We recommend that detailed protocols are deposited in 
Protocol Exchange, or a similar repository. If custom computer code has been used and is central 
to the conclusions of this paper, please insert a section into the Methods titled ‘Code availability’ 
and indicate within this section whether and how the code can be accessed, including any 
restrictions to access.] 
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[Author: We assume no power analysis was done to estimate sample size; per our reporting 
guidelines we will include the statement ‘No statistical methods were used to predetermine 
sample size.’ Please edit if appropriate.]Done 
[Author: In order to address the issue of cell line misidentification and cross-contamination, for 
any cell lines mentioned in the paper please provide source of the cell lines and indicate whether 
the cell lines have been correctly identified/authenticated (if so, by what methods). Also, please 
state whether cell lines have been tested for mycoplasma contamination.] 
[Author: We assume there was no randomization; per our reporting guidelines, we will include 
the statement “The experiments were not randomized”. Also, we assume that there was no 
blinding; per our reporting guidelines, we will include the statement “The investigators were not 
blinded to allocation during experiments and outcome assessment”. Please edit either of these 
statements if necessary.]Done 
METHODS 
Mice 
All mouse experiments were conducted in accordance with protocols approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of Texas Southwestern 
Medical Center (UTSW), and were in compliance with the relevant ethical regulations regarding 
animal research. Mice were housed in a 12:12 h light:dark cycle in a temperature-controlled 
room in the Animal Research Center of the UTSW, with free access to water and food. In each 
experiment, the age of the mouse is indicated in the text and in the figure. Littermate controls 
were used whenever possible. Both male and female mice were used on age-matched and 
gender-matched mice. No statistical methods wereused to predetermine sample size. All 
surgeries, echocardiographic, and MRI studies were carried out blinded to the genotype of the 
mice during the experiments and outcome assessments. CD1 mice (Charles River Laboratories) 
were used for wild-type studies. The Myh6cre (αMHCCre); Myh6cre-ERT2 (αMHCmERcremER); 
Myh6cre/activated calcineurin (CnA-Tg); Myh6cre/Rcan1 (Rcan1-Tg) transgenic lines, cardiac-
specific inducible deletion of Meis1fl/fl (Meis1-iKO) have been described previously9,29. The 
Hoxb13 floxed (Hoxb13fl/fl) mice were generated by The KOMP Repository 
(Hoxb13tm1a(KOMP)Wtsi; https://www.komp.org). Cardiac-specific deletion of Hoxb13 
(Hoxb13-KO or Hoxb13-iKO) was achieved by crossing Hoxb13fl/fl mice with αMHCcre mice or 
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αMHCmERcremER, respectively. The Myh6cre/CnA-Tg/Rcan1-Tg (CnA-Tg/Rcan1-Tg); 
αMHCcre/Meis1fl/fl Hoxb13fl/fl (DKO) and αMHCmERcremER/Meis1fl/fl Hoxb13fl/fl (DiKO) mice were 
generated by cross-breeding. Combinations of littermate floxed (fl/fl) [Author: Please clarify 
what is meant by F/F here. They are Meis1fl/fl or Hoxb13fl/f or Meis1fl/fl Hoxb13fl/fl without 
carrying Myh6cre] were used as controls for conditional deletion studies. Combinations of 
littermate fl/fl and age- and gender-matched αMHCmERcremER were used as controls for inducible 
deletion studies. MADM-ML-11GT/TG mice (JAX no. 030578) were obtained from Jackson 
Laboratory. Lineage analysis of Hoxb13-KO or DKO cardiomyocytes was performed by 
crossing Hoxb13-iKO or Meis1/Hoxb13-iKO with MADM TG/TG and MADM GT/GT mice to 
obtain αMHCmERcremER/Hoxb13-MADM GT/TG or Meis1-Hoxb13-MADM GT/TG mice. Age- 
and gender-matched αMHCmERcremER/ MADM GT/TG mice were used as control for the MADM 
study. 
Drug administration 
Tamoxifen (Sigma) was prepared by dissolving in sesame oil (Sigma) to a concentration of 10 
mg ml−1. Standard tamoxifen induction was done by injecting three times every other day by 
intraperitoneal injection at a dosage of 100 mg kg−1 per day per mouse. For the MADM clonal 
analysis, 14 consecutive injections of tamoxifen were administered and mice were euthanized 2 
weeks after the last injection. To monitor proliferation of endogenous cardiomyocytes, mice 
were administered daily with 0.25 mg ml−1 BrdU (Sigma) in the drinking water for up to 3 weeks 
after the first dose of tamoxifen injection. The BrdU mixture was prepared freshly and changed 
daily. Mice were euthanized at the same time of day to limit circadian variability. 
Murine model of MI 
Induction of adult anterior wall MI was performed as previously described30. In brief, ten-week-
old mice were subjected to MI by ligation of the proximal aspect of the LAD coronary artery. 
Mice were anaesthetized in an airtight chamber using 4% isoflurane, endotracheally intubated, 
and ventilated using a volume-control ventilator with 100% O2, supplemented with 2% 
vaporized isoflurane (Harvard Apparatus). Following lateral thoracotomy and pericardiectomy, 
the LAD coronary artery was identified along the anterior wall of the LV. Prolene sutures (6-0 
non-absorbable) was used to ligate the LAD. Proper occlusion of the LAD artery was noted by 
three criteria: immediate blanching of the LV anterior wall myocardium below the ligature, 
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echocardiographic assessment 7 days post-surgery showing an ejection fraction in the range of 
35–65%, and histological analysis. Vicryl sutures (6-0 absorbable) were used to close the 
thoracic cavity. Tamoxifen was administrated one week after MI. Mice were subjected to 
echocardiography at serial time points and then euthanized at 4 months after ligation. Hearts 
were collected and processed for histology and immunohistochemistry. Fibrotic scar size was 
measured using MIQuant31. Neonatal MI of P1 mice was performed as described elsewhere32. 
Prolene sutures (8-0 non-absorbable) was used to occlude the LAD. Hearts were collected 7 days 
after MI and processed for immunohistochemistry. 
Cardiac apical resection 
Apical resection of P1 mice was performed as described previously6. Sham procedures excluded 
apex amputation. Mice were subjected to echocardiography and then euthanized 21 days after 
resection. Dissected hearts were processed for histology. Fibrotic scar size was measured using 
ImageJ (National Institutes of Health). 
Murine model of TAC 
To perform TAC, eight-week-old DKO mice and corresponding control littermate mice were 
anaesthetized, restrained in a supine position, intubated and ventilated using a Harvard Apparatus 
respirator. Following dissection through the intercostal muscles, the aorta was identified and 
freed by blunt dissection. 7.0 silk suture was placed around the great vessel, tied around a blunt 
27-gauge needle. Sham-operated mice and wild-type littermates were used as controls. The 
surgical incision was closed and the mice were recovered on a warmer until they were returned 
to their cages. Cardiac function was evaluated by echocardiography for up to three weeks after 
surgery. The mice were euthanized, postmortem and histological studies were performed as 
described below. 
Voluntary wheel running 
Eight-week-old DKO mice and corresponding control littermates were randomly assigned to 
housing in individual cages with or without a running wheel for a total of four weeks. The mice 
were acclimatized with the running wheel for a week before the experiment. Rotation recordings 
are made every 5 min and integrated into the computer program. Echocardiography was 
performed to access left ventricular systolic function. Run distances were determined at the end 
of the study. 
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Transthoracic echocardiography 
Assessment of in vivo heart function on conscious, non-sedated mice was performed using a 
Vevo2100 micro-ultrasound system, MS400C probe (VisualSonics) at baseline, 1 week after 
injury, 1 week after tamoxifen-induced gene deletion, and 4, 8, 12 and 16 weeks after occlusion. 
Echocardiographic M-mode images were obtained from a parasternal short-axis view at the level 
of the papillary muscles. Left ventricular internal diameters at end diastole (LVIDd) and end 
systole (LVIDs) were measured from M-mode recordings. Six representative contraction cycles 
were selected for analysis, and average indexes (LVIDd, LVIDs and fractional shortening) were 
calculated for each mouse. All echocardiography measurements were performed in a blinded 
manner. 
Magnetic resonance imaging 
The cardiac function of mice was evaluated by cardiac MRI using a 7T small animal MRI 
scanner (Bruker) equipped with a 40 mm quadrature RF coil (ExtendMR). Under anaesthesia by 
inhalation of 1.5–3% isoflurane mixed in with medical-grade oxygen via nose cone, the animals 
were placed supine on a mouse holder, with a pneumatic respiratory sensor and ECG electrodes 
for cardiac sensing, head first with the heart centred with respect to the centre of the RF coil. The 
mice’s chests were shaved and conducting hydrogels were applied to optimize ECG contact 
between electrodes and mouse. All MRI acquisitions were gated using both cardiac and 
respiratory triggering. The core temperature was kept at 33 ± 2 °C to assure adequate and 
constant heart rate. Two-dimensional gradient echo images on three orthogonal planes 
(transverse, coronal and sagittal) were acquired to determine the long axis of the heart in each 
mouse. Axial images perpendicular to the long axis of the heart was chosen for Cine imaging. 
Cine images at 12 phases per cardiac cycle was obtained with an echo time of 1.5 ms, repetition 
time = ECG R–R interval/12 (typically, R-R interval ≈ 120–150 ms, which means repetition time 
(TR) ≈ 10 12.5 ms[Author: Please define RR, TR and NEX.]), flip angle of 45° and number of 
excitations (NEX) = 6 [Author: Please clarify what is meant by ‘number of average’.]). Each 
scan consisted of five to nine slices from apex to LV outflow with 1-mm thickness, no gap 
between slices, a matrix size of 128 × 128 and a field of view of 40 × 40 mm. Endocardial 
borders were manually traced for calculation of left ventricular end systolic volume (LVESV) 
and left ventricular end end diastolic volume (LVEDV) using ImageJ (v.1.47j) software. Total 
LV volumes were calculated as the sum of all slice volumes. Stroke volume was calculated as 
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LVEDV − LVESV. Cardiac output was calculated as stroke volume × heart rate. The LVEF was 
calculated as (LVEDV − LVESV)/LVEDV × 100%. Investigators performing MRI acquisition 
and analysis were blinded to the assignment of mice to groups. 
Histology 
Hearts were collected and fixed in 4% paraformaldehyde in PBS overnight at 4 °C and then 
processed for either paraffin or cryo embedding. H&E and Masson’s trichrome staining were 
performed according to standard procedures at UTSW core histology facility on paraffin 
sections. 
Immunofluorescence staining 
Immunostaining was performed according to previous descriptions30,33. In brief, heart 
cryosections were equilibrated with antigen retrieval buffer with 1 mM EDTA or epitope 
retrieval buffer (IHC World). Samples were permeabilized and blocked with 0.3% Triton X-100 
and 10% serum from the host animal of secondary antibodies in PBS for 20 min at room 
temperature. Then, samples were incubated overnight at 4 °C with the primary antibodies. After 
three washes with PBS, samples were incubated for 1 h at room temperature with corresponding 
fluorescence secondary antibodies conjugated to Alexa Fluor 488 or 555 (Invitrogen) at 1:400. 
The slides were mounted in Vectashield Antifade Mounting Medium (Vector Laboratories). 
Slides were viewed under Nikon fluorescence or Zeiss LSM 510 confocal microscopes. Primary 
antibodies used: phospho histone H3 Ser10 (EMD Millipore, 06-570; 1:100), aurora B kinase 
(Sigma, A5102; 1:25) to analyse cell cycle re-entry; troponin T, cardiac isoform Ab-1, clone 13-
11 (Thermo Scientific, MS-295-P1; 1:200), sarcomeric α-actinin (Abcam, ab68167; 1:200) to 
identify cardiomyocytes. Other antibodies used in the studies included Meis1/2(C-17) (Santa 
Cruz, sc-10599; 1:25), Hoxb13(F-9) (Santa Cruz, sc-28333; 1:10), Hoxa10(N-20) (Santa Cruz, 
sc-17158; 1:50), Hoxa11 (Abcam, ab28699; 1:50), Hoxd12(G-13) (Santa Cruz, sc-82922; 1:50), 
BrdU (Abcam, ab92837; 1:400), PCM1 (Sigma-Aldrich, HPA023370; 1:1,000). DAPI or 
Hoechst was used for nuclear staining. Images were obtained using a Nikon Eclipse Ni or Nikon 
A1 laser scanning confocal microscopes. 
WGA staining and cardiomyocyte size quantification 
WGA staining and quantification was performed as previously described30. In brief, the slides 
were incubated with WGA conjugated to Alexa Fluor 488 (50 mg ml−1, Life Technologies) for 
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1 h at room temperature following washing with PBS. To quantify the cross-sectional cell size, 
three to five independent hearts per group with three different views and positions, each from left 
and right ventricles, and septum were captured at 40× magnification. ImageJ was used to 
quantify the size of cardiomyocytes that were round and contained a nucleus. At least 500 cells 
per sample were quantified. 
Cardiomyocyte isolation 
Adult hearts were freshly collected and fixed in 4% paraformaldehyde at 4 °C overnight. The 
hearts were minced to smaller pieces and subsequently incubated with collagenase D (2.4 mg 
ml−1, Roche) and B (1.8 mg ml−1, Roche) for 12 h at 37°C using an end-over-end shaker. The 
supernatants were collected via 160-μm nylon mesh filter, and the procedure was repeated until 
no more cardiomyocytes were dissociated from the tissue. The isolated cardiomyocytes were co-
stained with connexin 43 (IHCWorld, IW-PA1026; 1:100) and DAPI (Sigma, D9542; 1:10,000) 
for further quantification. For nucleation counts, at least 300 cardiomyocytes per sample were 
quantified. 
Generation of phospho-specific Meis1 and Hoxb13 antibodies 
Prediction servers (https://www.rcsb.org/pdb/home/hom.do and 
http://www.cbs.dtu.dk/services/NetPhos/) were used to predict phosphorylation sites in Meis1 
and Hoxb13. We found that phosphorylation may occur at nine phosphorylation sites in Meis1 
(S21, T22, Y24, S196, S222, T223, T260 and T278) and six sites in Hoxb13 (T8, S204, S252, 
S256, K272 and K279). pMeis1 and pHoxb13 (4 μg ml−1, polyclonal) antibodies were raised 
(Abmart). Antibodies against four sites in Hoxb13 and six sites in Meis1 were successfully 
produced. The sequences of peptides are indicated in Extended Data Table 1. 
Western blotting 
Ventricles were collected and lysed in RIPA buffer with the addition of complete protease 
inhibitor cocktail (Roche). Protein concentration was quantified using Pierce BCA protein assay 
kit (Pierce Biotechnology), with three biological replicates. After separation via SDS–PAGE, 
proteins were transferred to nitrocellulose membranes (Bio-Rad), blocked in 5% skim milk/TBS 
and incubated with appropriate primary antibodies: Hoxb13 (Santa Cruz, sc-28333; 1:250), 
Hoxb13X (Santa Cruz, sc-28333X; 1:1000), Meis1/2(C-17) (Santa Cruz, sc-10599; 1:1,500), 
Meis1/2(C-17)X (Santa Cruz, sc-10599X; 1:2,000), calcineurin A (Abcam, ab71149; 1:2,000), 
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Rcan1 (C-terminal) (Sigma, D6694; 1:1,500), GAPDH (EMD Milipore, AB2302; 1:5,000), 
Hoxa10(N-20) (Santa Cruz, sc-17158; 1:1,000), Hoxa11(5A3) (Abcam, ab28699; 1:1,000), 
Hoxd12(G-13) (Santa Cruz, sc-82922,;1:1,000), phospho-Meis1 (Abmart; 1:500), phospho-
Hoxb13 (Abmart; 1:500), p21 Waf1/Cip1 (12D1) (Cell Signaling, 2947; 1:1,000), p15/16 (Santa 
Cruz, sc-377412; 1:1,000), α-tubulin (Milipore, 04-1117; 1:2,000). Horseradish peroxidase-
conjugated peroxidase anti-mouse, anti-rabbit, anti-chicken or anti-goat antibodies (Jackson 
ImmunoResearch, 115-035-166, 111-035-144, 703-035-155, 705-035-147; 1:25,000–1:50,000) 
were used as secondary antibodies. The membranes were explored using Licor Odyssey Fc 
system and quantified by Image Studio Lite v.5.2 software. 
Site-directed mutagenesis of serine 204 of Hoxb13 
Phospho-mimetic (S204A) and non-phosphorylated (S204D, S204E) Hoxb13 mutants were 
constructed from pCMV-murine Hoxb13-EGFP using GeneArt Site-Directed Mutagenesis Plus 
Kit (Life Technologies, cat no. A14604). The point mutations were produced by overlap 
extension PCR with primers bearing mutations as follows: Hoxb13_S204A_F, 
GCGTTTGCAGAGCCCGCCGTCCAGCACCCTCCT; Hoxb13_S204A_R, 
AGGAGGGTGCTGGACGGCGGGCTCTGCAAACGC; Hoxb13_S204D_F, 
GCGTTTGCAGAGCCCGACGTCCAGCACCCTCCT; Hoxb13_S204D_R, 
AGGAGGGTGCTGGACGTCGGGCTCTGCAAACGC; Hoxb13_S204E_F, 
GCGTTTGCAGAGCCCGAGGTCCAGCACCCTCCT; Hoxb13_S204E_R, 
AGGAGGGTGCTGGACCTCGGGCTCTGCAAACGC. 
All mutations were verified by DNA sequencing. 
Cre lentiviral production 
Host 293T cells were plated on 10-cm plates until 70% confluence, at which point they were 
transfected with 5 μg of Cre-ires-puro vector (Addgene Plasmid no. 30205) along with 3 μg 
pAX2 and 2 μg VSVG packaging plasmids using Lipofectamine 3000 Reagent (Invitrogen). 
Fourty-eight hours later, the supernatant was collected and spun at 300g for 5 min to remove 
cells. The resulting lentivirus-containing supernatant was filtered through a 0.45-μm 
polyethersulfone membrane filter (Thermo Scientific, 725-2545), and stored at −80 °C or used 
immediately. 
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Generation of DKO cardiac fibroblasts 
Adult murine cardiac fibroblasts were isolated from eight-week-old male Meis1fl/fl Hoxb13fl/fl 
hearts. Hearts were collected and rinsed in Gerard isotonic solution. Subsequently, hearts were 
minced and submitted to digestion with Gerard solution containing 1 mg ml−1 type II collagenase 
(Sigma-Aldrich) at 37 °C for 1 h with gentle shaking. Repeated digestions and centrifugations 
were performed, and cardiac fibroblasts were obtained by plating the cells in 10% FBS, DMEM-
F12 (ThermoFisher Scientific), and 20 ng ml−1 FGF (Merck Millipore). Fresh medium 
containing FGF was added every 2 days. After reaching 80–100% confluence (3 weeks), cardiac 
fibroblasts were passaged to a six-well plate to perform further experiments. For Cre lentivirus 
infection, in one well of the six-well plate, when cells reached about 60% confluence, the 
medium was removed and replaced with 1 ml Optimem supplemented with 16 μg ml−1 
polybrene. One millilitre of Cre lentivirus was added dropwise to the plate. Lentivirus without 
Cre was used as control. After 48 h, puromyocin (ThermoFisher Scientific) selection with 
medium containing 1 μg ml−1 puromycin was added for up to two weeks to select for lentiviral-
infected cells. 
Cell culture, transfection, and immunostaining 
Culture cells were maintained at 37°C in a humidified incubator containing 5% CO2. 293T cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA, 
USA) supplemented with 10% (vol/vol) fetal bovine serum (FBS; Hyclone, Logan, UT, USA) 
and 1% penicillin/streptomycin. Cardiac fibroblasts (CFs) were cultured in 10% FBS, DMEM-
F12. CFs were grown on a poly-L-lysine-coated covers slips 24 h before transfection. When the 
cells were 60% confluent, transient transfection was performed with Lipofectamine 3000 
Reagent (ThermoFisher Scientific) according to the manufacturer’s protocol. After 48 h, CFs 
were fixed and permeabilized with ice-cold acetone for 15 min at −20 °C, then blocked with PBS 
containing 0.03% Triton X-100 and 3% BSA for 20 min at room temperature. CFs were then 
washed three times with PBS and stained for 1 h at room temperature with rhodamine–phalloidin 
(Cytoskeleton; 1:400). The cells were mounted by Prolong gold containing DAPI (Invitrogen) 
and viewed under a Nikon fluorescence microscope. 
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Coimmunoprecipitation 
Mouse hearts at P1 and P7 (n = 3 for each) were collected and lysed in immunoprecipitation lysis 
buffer: 2.5mM Tris, pH7.4, 150 mM NaCl, 1 mM EDTA, 1% NP40, 5% glycerol. Protease 
inhibitor cocktail and phosphatase inhibitor were included at all times. Five microgram of 
primary antibodies were used for binding with 1 mg digested heart samples with gentle rocking 
at 4 °C overnight. Protein A agarose beads (Calbiochem) were added to the mixture and 
incubation was continued with gentle rocking for 4 h at 4 °C. After centrifugation for 30 s at 
4 °C, the pellets were washed three times with 1 ml immunoprecipitation lysis buffer. Final 
pellets were resuspended with 25 μl 2× SDS sample buffer. Negative control IgG is used in place 
of a primary antibodies to evaluate nonspecific binding. The samples were then analysed by 
western blotting. The same procedure was done using DKO heart lysate as negative control for 
protein binding. 
Calcineurin binding assay 
N-terminally His6-tagged human calcineurin A (α-isoform, truncated at residue 400), was 
expressed in tandem with the calcineurin B subunit in Escherichia coli BL21 (DE3) cells 
(Invitrogen) and affinity purified using Ni-NTA-agarose with methods identical to the 
purification of His-tagged yeast calcineurin34. A 16-amino-acid peptide corresponding to 
Hoxb13 residues 255–270, or a mutant version with residues 260, 262, 264 and 265 changed to 
alanine, or a positive control (Saccharomyces cerevisiae Dig2 residues 95–116 containing a 
PxIxIT site) were fused to GST in vector pGX4T-3. Cell lysates from bacteria expressing the 
GST fusion peptides were obtained as in34. Bacterial cell lysate (50–100 μg) was used to test co-
purification with 2 μg of purified His6-calcineurin as described
34. Co-purifying proteins were 
observed by western blotting with mouse GST (Bio Legend) and His-tag monoclonal primary 
antibodies and an IRDye680RD goat anti-mouse secondary antibody (LiCor), and imaged with 
the Li-Cor Odyssey imaging system. 
Proximity ligation assay 
PLA (Duolink, no. DUO92101, Sigma) was performed according to the manufacturer’s 
instructions. Cryosections at P7 were used for all studies. DKO hearts were used as negative 
control for PLA proteins. Antigen retrieval and permeabilization steps were the same as per 
standard immunostaining procedure. 
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TUNEL assay 
Cryo-sections underwent immunofluorescent staining for cardiac troponin T as abovementioned. 
Following incubation with corresponding secondary antibody conjugated to Alexa Fluor 555 
(Invitrogen), TUNEL staining was performed according to manufacturer’s guideline (In situ Cell 
Death Detection Kit, Fluorescein, Roche). All staining was performed on three hearts per group, 
with three sections per heart. 
ChIP–seq 
Ventricles from three P15 mouse hearts were used as biological triplicates for the ChIP–seq 
experiments. Chromatin immunoprecipitation was performed as previously described35,36, using 
the following antibodies: Meis1/2 (Santa Cruz, sc-10599X; 1:200) or Hoxb13 (GeneTex, 
GTX129245; 1:100). ChIP–seq libraries were generated using NEBNext Ultra II DNA Library 
Prep Kit for Illumina (NEB, E7645L) according to manufacturer’s protocol. Final ChIP–seq 
libraries were pooled and sequenced on an Illumina Nextseq 500 system using the 75-bp high 
output sequencing kit for single-end sequencing. Reads were quality trimmed and mapped to 
mouse genome (mm10) by bowtie2 (v.2.2.3)37 with parameter “–sensitive”. Uniquely mapped 
reads were filtered by removing alignments with mapping quality less than 10, and removing 
duplicate reads identified by Picard MarkDuplicates (v.1.127) 
(http://broadinstitute.github.io/picard). Enriched regions (peaks) were identified using the IDR 
pipeline38 and spp. package39. Peak regions were annotated by HOMER40. Genome-wide core 
motifs were found for Meis1 and Hoxb13 using HOMER (scanMotifGenomeWide.pl). Input 
samples were used as reference controls for background correction. Genes with peaks in their 
promoters and also including the core motif were used to generate the 3 categories: Meis1, 
Hoxb13 and Meis1–Hoxb13 (Venn diagram). Gene ontology analysis for ChIP–seq peak target 
genes was performed using Metascape41. 
Statistics and reproducibility 
Differences between groups were examined for statistical significance using unpaired two-sided 
Student’s t-test. All bar graphs represent mean ± s.e.m. Statistical significance was assessed as 
*P < 0.05, **P < 0.01 and *** P < 0.001. P values are shown in graphs. All ChIP–seq samples 
were derived from n = 3 biologically independent samples. The sample sizes were as follows: 
Fig. 1f, n = 11 mice per Hoxb13fl/fl group, n = 9 mice per Hoxb13-KO group; Fig. 1g, h, n = 3 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 MS nr: 2018-11-17051D 
Page 27 of 36 
biologically independent samples per group; Fig. 1i, n = 7 mice per MHC MCM group, n = 10 
mice per Hoxb13-iKO group; Fig. 1j n = 4 biologically independent samples per control group (3 
MHC MCM, 1 Hoxb13fl/fl), n = 3 biologically independent samples per Hoxb13-iKO group; Fig. 
1k, l, n = 5 biologically independent samples per control group (3 MHC MCM, 2 Hoxb13fl/fl), 
n = 4 biologically independent samples per Hoxb13-iKO group; Fig. 1m, n, n = 4 biologically 
independent samples per control group, n = 3 biologically independent samples per Hoxb13-iKO 
group; Fig. 1o, n = 3 biologically independent samples per group; Fig. 1p, n = 11 mice per 
Hoxb13fl/fl group, n = 12 mice per Hoxb13-KO group; Fig. 2b, n = 8 mice per control group (5 
MHC MCM, 3 Meis1fl/fl Hoxb13fl/fl), n = 11 mice per DiKO group; Fig. 2c, n = 4 biologically 
independent samples per control group, n = 3 biologically independent samples per DiKO group; 
Fig. 2d, n = 3 biologically independent samples per group; Fig. 2e, n = 8 biologically 
independent samples per control group and n = 6 biologically independent samples per DiKO 
group at one week post-deletion, n = 3 biologically independent samples per group at two 
months post-deletion; Fig. 2f, n = 5 biologically independent samples per control group and 
n = 6 biologically independent samples per DiKO group at one week post-deletion, n = 3 
biologically independent samples per control group and n = 4 biologically independent samples 
per DiKO group at two months post-deletion; Fig. 2g, n = 3 biologically independent samples 
per group; Fig. 2h, i, n = 4 biologically independent samples per group; Fig. 2j, n = 4 mice per 
control group, n = 3 mice per DiKO group; Fig. 2l, n = 6 biologically independent samples per 
group; Fig. 2n, n = 13 mice per control group (10 MHC MCM, 3 Meis1fl/fl Hoxb13fl/fl), n = 8 
mice per DiKO group; Fig. 2p, q, n = 6 mice per group; Fig. 2r, n = 8 mice per control group, 
n = 5 mice per DiKO group; Fig. 3n, n = 6 biologically independent samples per group; Fig. 4a–
d, n = 3 biologically independent samples per group; Fig. 4e, for sham cohort: n = 4 mice per 
wild-type group, n = 3 mice per CnA-Tg group, n = 5 per CnA-Tg/Rcan1-Tg group, for resected 
cohort: n = 4 mice per wild-type group, n = 7 mice per CnA-Tg group, n = 8 per CnA-Tg/Rcan1-
Tg group; Fig. 4g, n = 5 biologically independent samples per wild-type group, n = 6 
biologically independent samples per CnA-Tg group, n = 4 biologically independent samples per 
CnA-Tg/Rcan1-Tg group; Fig. 4i, n = 5 biologically independent samples per wild-type group, 
n = 4 biologically independent samples per Rcan1-Tg group; Fig. 4j, n = 5 mice per wild-type 
group, n = 8 mice per Rcan1-Tg group; Extended Data Fig. 1a, n = 9 mice per MHC MCM 
group, n = 6 mice per Meis1-iKO group; Extended Data Fig. 1j, n = 3 biologically independent 
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experiments; Extended Data Fig. 1l, n = 11 mice per group; Extended Data Fig. 1n, n = 5 mice 
per control group (3 MHC MCM, 2 Hoxb13f/f), n = 6 mice per Hoxb13-iKO group; Extended 
Data Fig. 2c, n = 13 mice per control group, n = 11 mice per Hoxb13-KO group; Extended Data 
Fig. 2d, n = 10 mice per control group, n = 6 mice per Hoxb13-KO group; Extended Data Fig. 
2e, n = 6 biologically independent samples per group; Extended Data Fig. 2g, for MI cohort: 
n = 14 mice per control group, n = 8 mice per Hoxb13-iKO group, for sham cohort: n = 10 mice 
per control group, n = 6 mice per Hoxb13-iKO group; Extended Data Fig. 2h, n = 8 biologically 
independent samples per group; Extended Data Fig. 2i, for MI cohort: n = 14 mice per control 
group, n = 8 mice per Hoxb13-iKO group, for sham cohort: n = 10 mice per control group, 
n = 10 mice per Hoxb13-iKO group; Extended Data Fig. 3a, n = 9 mice per Meis1fl/fl Hoxb13fl/fl 
group, n = 7 mice per DKO group; Extended Data Fig. 3b, n = 3 biologically independent 
samples per group; Extended Data Fig. 3c, n = 3 biologically independent samples per Meis1fl/fl 
Hoxb13fl/fl group, n = 4 biologically independent samples per DKO group; Extended Data Fig. 
3d, n = 5 biologically independent samples per group; Extended Data Fig. 3e, n = 4 biologically 
independent samples per group; Extended Data Fig. 3f, n = 3 biologically independent samples 
per Meis1fl/fl Hoxb13fl/fl group, n = 4 biologically independent samples per DKO group; Extended 
Data Fig. 3g, n = 4 mice per Meis1fl/fl Hoxb13fl/fl group, n = 5 mice per DKO group; Extended 
Data Fig. 3h, n = 3 biologically independent samples per Meis1fl/fl Hoxb13fl/fl group, n = 5 
biologically independent samples per DKO group; Extended Data Fig. 3i, n = 4 biologically 
independent samples per Meis1fl/fl Hoxb13fl/fl group, n = 4 biologically independent samples per 
DKO group; Extended Data Fig. 3j, n = 3 biologically independent samples per group; Extended 
Data Fig. 3k, n = 3 mice per Meis1fl/fl Hoxb13fl/fl group, n = 5 mice per DKO group; Extended 
Data Fig. 4b–f, for sham cohort: n = 6 mice per Meis1fl/fl Hoxb13fl/fl group, n = 10 mice per DKO 
group, for TAC cohort: n = 7 mice per Meis1fl/fl Hoxb13fl/fl group, n = 11 mice per DKO group; 
Extended Data Fig. 4h, for sham cohort: n = 5 biologically independent samples per Meis1fl/fl 
Hoxb13fl/fl group, n = 6 biologically independent samples per DKO group, for TAC cohort: n = 4 
biologically independent samples per Meis1fl/fl Hoxb13fl/fl group, n = 6 biologically independent 
samples per DKO group; Extended Data Fig. 4j–n, for sham cohort: n = 6 mice per Meis1fl/fl 
Hoxb13fl/fl group, n = 10 mice per DKO group, for exercise cohort: n = 6 mice per group; 
Extended Data Fig. 4p, for sham cohort: n = 5 biologically independent samples per Meis1fl/fl 
Hoxb13fl/fl group, n = 6 biologically independent samples per DKO group, for exercise cohort: 
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n = 6 biologically independent samples per group; Extended Data Fig. 5g, n = 5 biologically 
independent samples per control group, n = 3 biologically independent samples per DiKO; 
Extended Data Fig. 6c, n = 4 biologically independent samples per group; Extended Data Fig. 
6d, n = 13 mice per control group (10 MHC MCM, 3 Meis1fl/fl Hoxb13fl/fl), n = 8 mice per DiKO 
group; Extended Data Fig. 6e, f, for sham cohort: n = 9 mice per group, for MI cohort: n = 13 
mice per control group (10 MHC MCM, 3 Meis1fl/fl Hoxb13fl/fl), n = 8 mice per DiKO group; 
Extended Data Fig. 6i, j, n = 6 mice per group; Extended Data Fig. 6k, n = 9 mice per group; 
Extended Data Fig. 6l–q, n = 13 mice per control group (10 MHC MCM, 3 Meis1fl/fl Hoxb13fl/fl), 
n = 8 mice per DiKO group; Extended Data Fig. 8i, j, n = 3 biologically independent samples per 
group; Extended Data Fig. 9a, n = 18 mice per wild-type group, n = 11 mice per CnA-Tg group, 
n = 14 mice per Rcan1-Tg group, n = 6 per CnA-Tg/Rcan1-Tg group; Extended Data Fig. 9b, 
n = 7 mice per wild-type group, n = 6 mice per CnA-Tg group, n = 16 mice per Rcan1-Tg group, 
n = 4 per CnA-Tg/Rcan1-Tg group. 
Reporting summary 
Further information on research design is available in the Nature Research Reporting Summary 
linked to this paper. 
Data availability 
The data that support the findings of this study are available within the paper and its 
Supplementary Information. Source Data for Figs. 1–4 and Extended Data Figs. 1–6, 8, 9 are 
provided with the online version of the paper. ChIP–seq data have been deposited in the Gene 
Expression Omnibus (GEO) under accession number GSE141769. Data or other materials are 
available from the corresponding author upon reasonable request. 
<jrn>30. Nakada, Y. et al. Hypoxia induces heart regeneration in adult mice. Nature 541, 
222–227 (2017).  </jrn> 
<jrn>31. Nascimento, D. S. et al. MIQuant--semi-automation of infarct size assessment in 
models of cardiac ischemic injury. PLoS ONE 6, e25045 (2011).  </jrn> 
<jrn>32. Mahmoud, A. I., Porrello, E. R., Kimura, W., Olson, E. N. & Sadek, H. A. 
Surgical models for cardiac regeneration in neonatal mice. Nat. Protoc. 9, 305–311 
(2014).  </jrn> 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 MS nr: 2018-11-17051D 
Page 30 of 36 
<jrn>33. Kimura, W. et al. Hypoxia fate mapping identifies cycling cardiomyocytes in the 
adult heart. Nature 523, 226–230 (2015).  </jrn> 
<jrn>34. Goldman, A. et al. The calcineurin signaling network evolves via conserved 
kinase-phosphatase modules that transcend substrate identity. Mol. Cell 55, 422–435 
(2014).  </jrn> 
<jrn>35. Wang, Z. et al. Mechanistic basis of neonatal heart regeneration revealed by 
transcriptome and histone modification profiling. Proc. Natl Acad. Sci. USA 116, 
18455–18465 (2019).  </jrn> [Author: This reference has been updated to the final 
published details. OK?] 
<jrn>36. Hashimoto, H. et al. Cardiac reprogramming factors synergistically activate 
genome-wide cardiogenic stage-specific enhancers. Cell Stem Cell 25, 69–86 (2019).  
</jrn> 
<jrn>37. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. 
Methods 9, 357–359 (2012).  </jrn> 
<jrn>38. Li, Q., Brown, J. B., Huang, H. & Bickel, P. J. Measuring reproducibility of high-
throughput experiments. Ann. Appl. Stat. 5, 1752–1779 (2011). </jrn> 
<jrn>39. Kharchenko, P. V., Tolstorukov, M. Y. & Park, P. J. Design and analysis of 
ChIP–seq experiments for DNA-binding proteins. Nat. Biotechnol. 26, 1351–1359 
(2008).  </jrn> 
<jrn>40. Heinz, S. et al. Simple combinations of lineage-determining transcription factors 
prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 
38, 576–589 (2010).  </jrn> 
<jrn>41. Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis 
of systems-level datasets. Nat. Commun. 10, 1523 (2019).  </jrn> 
Acknowledgments We thank S. Zhang for MRI studies at the Mouse MRI Core, Advanced Imaging Research 
Center, University of Texas Southwestern Medical Center; J. Shelton for assistance with histology; H. I. May for 
conducting mouse surgeries; J. Heinrich for helping with voluntary exercise; J. Xu, X. Liu and Y. Jung Kim from 
the Sequencing Core Facility in Children’s Research Institute in University of Texas Southwestern Medical Center 
for performing the Illumina sequencing. The UTSW mouse MRI facility is supported by an NIH shared 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 MS nr: 2018-11-17051D 
Page 31 of 36 
instrumentation grant 1S10OD023552-01. H.A.S. is supported by grants from the NIH (1R01HL115275 and 
5R01H2131778), National Aeronautics and Space Administration (NNX-15AE06G), American Heart Association 
(16EIA27740034), Cancer Prevention and Research Institute of Texas (RP160520), Hamon Center for Regenerative 
Science and Medicine, and Fondation Leducq (Redox Regulation of Cardiomyocyte Renewal). M.S.C. and J.R. are 
funded by NIH R01GM119336. B.A.R was supported by grants from the NIH (R01 HD101006, R01 HL072016). 
J.A.H is supported by grants from NIH (R01 HL120732, R01 HL128215, R01 HL126012). N.U.N.N. is supported 
by AHA Postdoctoral Fellowship 19POST34450039. Z.W. was supported by a predoctoral fellowship from the 
American Heart Association and the Harry S. Moss Heart Trust (19PRE34380436). N.T.L. is supported by a 
Haberecht Wildhare-Idea Research Grant. 
Author contributions N.U.N.N., D.C.C. and S.A.M. conducted calcineurin and Rcan1-related experiments and 
interpreted results. N.U.N.N., F.X., Y.N., S.L., S.A.M., J.M., D.C.C., Victor Le., K.A.Z., H.W.E.-F. and W.M.E. 
conducted immunofluorescent staining. F.X., D.C.C., N.U.N.N. and X.M. designed and performed phosphorylated 
antibody experiments and interpreted results. N.U.N.N., F.X. and M.E.H. conducted immunoprecipitation and PLA 
experiments. N.U.N.N., F.X. and S.L. conducted TUNEL assay. Z.W. and N.U.N.N. conducted ChIP–seq 
experiments. M.K., C.X., C.G.A.-N, W.L.W.T, R.S.F. and Z.W. interpreted ChIP–seq results. E.V., F.X., S.R.A. and 
N.U.N.N. conducted cardiac fibroblast experiments and interpreted results. N.U.N.N., I.M.-M., Victoria Le., M.S.M, 
conducted TAC and exercise-related experiments. N.U.N.N., M.S.A., M.S.M. and I.M.-M. conducted BrdU-
labelling experiments. N.L., F.X. and N.U.N.N. conducted MADM-related experiments and interpreted results. J.R. 
and M.S.C. designed and performed calcineurin-binding assay. S.L., and N.U.N.N. performed mouse surgeries. S.L., 
D.C.C., J.J.S. and N.U.N.N. conducted echocardiography experiments and interpreted results. S.T. and N.U.N.N. 
managed mouse colonies. N.U.N.N. designed and conducted experiments, interpreted results and contributed to 
manuscript preparation. J.A.H. interpreted results. B.A.R. interpreted results and contributed to manuscript 
preparation. H.A.S. designed the experiments, conceived the project and contributed to manuscript 
preparation.[Author: In author contributions: (1) H.I.M. is listed but is not an author. Please check and correct. (2) 
there are two authors with initials V.L. Please list them as Victor Le and Victoria Le.]  
Competing interests The authors declare no competing interests. 
Additional Information 
Supplementary information is available for this paper at 
Correspondence and requests for materials should be addressed to H.A.S. 
Peer review information Nature thanks Norbert Frey and the other, anonymous, reviewer(s) for their contribution 
to the peer review of this work. 
Reprints and permissions information is available at http://www.nature.com/reprints. 
[Author: Please ensure that the following information is included in the figure legends where 
relevant. Sample size (exact n number); a statement of replicability (how many times was 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 MS nr: 2018-11-17051D 
Page 32 of 36 
experiment replicated in the lab); description of sample collection (clarify whether technical or 
biological replicates and include how many animals, litters, cultures, etc.); state the statistical test 
used and give P values; define centre values (median or average) and error bars. For 
figures/images that are reproduced or adapted from a third party, it is important that you confirm 
that permission has been obtained and that appropriate acknowledgement of the copyright holder 
is given.] 
Extended Data Fig. 1 | Additional characterization of Meis1-iKO, Hoxb13-KO, and 
Hoxb13-iKO mice. a, Echocardiographic assessment of LVEF in Meis1-iKO hearts at the 
indicated time points post-MI. b, Immunostaining of Meis1-interacting Hox proteins (red), 
cardiac troponin T (green), and nucleus (blue) at P1, P7 and 7 days after P1 MI. c, Western blot 
analysis of Meis1 and Hox proteins during regenerative stages. GAPDH serves as loading 
control. d, Coimmunoprecipitation of Meis1 from total heart extracts at P1 and P7. e, 
Coimmunoprecipitation from Fig. 1c, with negative controls (IgG and DKO heart). f, 
Coimmunoprecipitation from Fig. 1d, with negative controls (IgG and DKO heart). g, PLA of 
Meis1 and Hoxb13 in P7 DKO heart; serves as negative control for PLA assay in Fig. 1e. h, 
Schematic of targeting strategy for generation of cardiomyocyte-specific Hoxb13 mutants. 
Partial map of the Hoxb13 floxed allele (top), and of the knockout allele (bottom) following 
cardiomyocyte-specific Cre-mediated excision. Exons and loxP sites are indicated as rectangles 
and triangles, respectively. i, PCR analysis of heart DNA obtained by crossing Hoxb13loxP/loxP 
(female) mutants with MHC-cre (male) transgenic mice. Left lane shows Hoxb13loxP/loxP. Middle 
lane indicates cardiomyocyte-specific Cre. Right lane indicates that the deleted allele is present 
in cardiomyocyte DNA of this offspring. j, Top, western blot of protein extracts from hearts of 
constitutive (left) or inducible (right) Hoxb13 knockout and Hoxb13fl/fl littermate mice. GAPDH 
serves as loading control. Bottom, densitometry quantification of the above western blot. k, 
Control and Hoxb13-KO P14 hearts stained for Meis1 (red), cardiac troponin T (green), and 
nucleus (blue). Arrowheads indicated Meis1-expressing cardiomyocytes, and arrows indicate 
Meis1-expressing non-cardiomyocytes. l, Representative echocardiography, ejection fraction and 
fraction shortening in Hoxb13-KO mice P14 hearts. m, Representative images of Masson’s 
trichrome staining of control and Hoxb13-iKO hearts at 14 days post-deletion. n, representative 
images of immunostaining for TUNEL (green), cardiac troponin T (red), and nucleus (blue) (left) 
and quantification (right) 14 days post-deletion. Arrow indicates TUNEL-positive 
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cardiomyocytes. Data are mean ± s.e.m.; unpaired two-sided t-test. Data in b–f, g, i, k, m were 
independently repeated three times with similar results. *P < 0.05, **P < 0.01, ***P < 0.001. 
For gel source data, see Supplementary Fig. 1. For n values, see Methods. Scale bars: 10 μm (b, 
k, n), 50 μm (g), 1 mm (m). 
Extended Data Fig. 2 | Assessment of Hoxb13-KO and Hoxb13-iKO hearts post-MI. a, 
Schematic of MI model in Hoxb13-KO mice. b–d, Representative echocardiography (b), heart 
weight/body weight (c), and wet-to-dry lung weight ratio (d) in Hoxb13-KO mice 16 weeks after 
MI. e, Representative serial Masson’s trichrome staining in transversal sections (left) and 
quantification of fibrotic scars (right) in Hoxb13-KO MI hearts at 16 weeks after injury. f, 
Schematic of MI model in Hoxb13-iKO mice. g, h, Heart weight/body weight (g) and wet-to-dry 
lung weight ratio (h) in Hoxb13-iKO mice 16 weeks after MI. i, Serial echocardiography of 
Hoxb13-iKO MI and sham mice. Data are mean ± s.e.m.; unpaired two-sided t-test. *P < 0.05, 
**P < 0.01, ***P < 0.001. For n values, see Methods. Scale bar 1 mm (e). 
Extended Data Fig. 3 | Concurrent knockout of Meis1 and Hoxb13 preserves 
cardiomyocyte proliferative capacity. a–g, Assessment of control and DKO hearts at P28. a, 
Representative images of haematoxylin and eosin -stained heart sections and heart weight/body 
weight ratio. b, Representative images of WGA staining and cardiomyocyte cross-sectional area 
quantification. c, Representative images of immunostaining for pH3 (green), cardiac troponin T 
(red), and nucleus (blue) (left) and the percentage (right) of mitotic cardiomyocytes (arrow). 
Arrowhead indicates cardiomyocytes with sarcomere disassembly. d, Representative images of 
immunostaining for aurora B kinase (green), cardiac troponin T (red), and nucleus (blue) (left) 
showing the percentage (right) of cardiomyocytes undergoing cytokinesis (arrow). e, f, Total 
number of cardiomyocytes (e) and quantification of nucleation (f). g, Representative 
echocardiography and LV systolic function. h–k, Assessment of control and DKO hearts at 6 
months of age. h, Representative images of immunostaining for pH3 (green), cardiac troponin T 
(red), and nucleus (blue) (left) and the percentage (right) of mitotic cardiomyocytes (arrow). 
Arrowhead indicates cardiomyocytes with sarcomere disassembly. i, Representative images of 
immunostaining for aurora B kinase (green), cardiac troponin T, and nucleus (blue) (left) and the 
percentage (right) of cardiomyocytes undergoing cytokinesis (arrow). j, Representative images 
of WGA (green), cardiac troponin T (red), and nucleus (blue) staining (left) and cardiomyocyte 
CSA quantification (right). k, LV systolic function quantified by ejection fraction in 6-month-old 
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DKO mice. Data are mean ± s.e.m.; unpaired two-sided t-test. *P < 0.05, **P < 0.01, 
***P < 0.001. For n values, see Methods. Scale bars: 10 μm (c, d, f, h, i), 50 μm (b, j), 1 mm (a). 
Extended Data Fig. 4 | Loss of Meis1 and Hoxb13 attenuates both pathological and 
physiological hypertrophic responses. a, Schematic representing the TAC model. b, 
Representative images of M-mode echocardiography (top) and quantification of ejection fraction 
(bottom), demonstrating improved LVEF in the DKO mice compared with wild-type mice three 
weeks following TAC. c, Heart weights, showing significantly higher heart weight in the wild-
type group. d, Tibia length was similar in both groups. e, f, The ratio of heart weight/body 
weight (e) and heart weight/tibial length (f) indicate that the DKO mice have a blunted response 
to pressure overload. g, Representative images of mouse heart sections stained with 
haematoxylin and eosin (top) or Masson’s trichrome (bottom) three weeks after surgery. h, 
Representative confocal images of cardiomyocyte WGA staining (left) and CSA quantification 
(right), confirming the blunted hypertrophic response in the DKO hearts in response to pressure 
overload. i, Schematic representation of the exercise protocol. j, Representative images of 
echocardiography (top) and ejection fraction quantification (bottom), demonstrating no 
difference in ejection fraction at baseline and after exercise. k, Running distance of control and 
DKO mice over four weeks, demonstrating no difference between the two groups. l, Heart 
weight. m, The ratio of heart weight/body weight suggests that both control and DKO hearts 
respond to exercise-induced cardiac hypertrophy. n, The ratio of heart weight/tibia length also 
indicates cardiac hypertrophy in both groups in response to exercise. o, Representative images of 
mouse heart sections stained with either haematoxylin and eosin (top) or Masson’s trichrome 
(bottom) four weeks after exercise. p, Confocal images of cardiomyocyte WGA staining and 
CSA quantification. Data are mean ± s.e.m.; unpaired two-sided t-test. Images in g, o are 
representative of six independently performed experiments with similar results. *P < 0.05, 
**P < 0.01, ***P < 0.001. For n values, see Methods. Scale bars: 10 μm (h, p), 1 mm (g, o). 
Extended Data Fig. 5 | Inducible knockout of Meis1 and Hoxb13 promotes sarcomere 
disassembly and cardiomyocyte division. a, Representative images of Masson’s trichrome 
staining of DiKO hearts four weeks after deletion. b, c, Disassembled sarcomere cardiomyocytes 
in DiKO hearts one week after deletion, demonstrated by cardiac troponin T (red) (b) or 
sarcomeric α-actinin (red) (c).[Author: There is no legend for d. Please check and correct.] d, 
Representative images of immunostaining for TUNEL (green) and cardiac troponin T (red) in 
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DiKO hearts one week and two months after deletion, as shown in Fig. 2e. e, f, Representative 
images of immunostaining for pH3 (green), cardiac troponin T (red), and nucleus (blue), 
showing additional examples of proliferating cardiomyocytes in DiKO hearts at (e) one week 
and (f) two months after gene deletion. g, Representative images of immunostaining for aurora B 
kinase (green), cardiac troponin T (red) and nucleus (blue) (left) and the percentage (right) of 
proliferating cardiomyocytes (arrow) one week after gene deletion. h, Additional examples of 
cytokinetic cardiomyocytes in DiKO hearts one week after gene deletion. Images in a–c are 
representative of three independently performed experiments with similar results. Scale bars, 
10 μm (b, d–h), 20 μm (c), 1 mm (a). 
Extended Data Fig. 6 | LV function of DKO hearts after MI. a–c, Analysis of DKO hearts 
post MI. a, Schematic of experiments. b, c, Western blot analysis (b) and quantification (c), 
showing decrease in expression of the negative regulators of proliferation p21, p15 and p16 in 
DKO hearts[Author: OK?]. d–f, Heart weight/body weight (d), body weight (e) and heart weight 
(f) in control and DiKO mice 16 weeks after injury. g, Representative images of the whole hearts 
at 16 weeks post-MI. The white arrow indicated a region with cell death and the yellow arrow 
indicates the dilated left atrial appendage. h, Additional representative serial Masson’s 
trichrome-stained transversal sections, as in Fig. 2l. i, j, LV cardiac index (i) and heart rate (j) in 
DiKO mice 16 weeks after MI measured by MRI. k, LVEF for sham groups.  l–q, Cardiac 
function analysis for left-ventricular end-diastolic anterior wall thickness (l), left-ventricular end-
diastolic internal diameter (m), left-ventricular end-diastolic volume (n), left-ventricular end-
diastolic posterior wall thickness (o), left-ventricular end-systolic internal diameter (p), and left 
ventricular end-systolic volume (q) in DiKO and control mice after MI. Data are mean ± s.e.m.; 
unpaired two-sided t-test. *P < 0.05, **P < 0.01, ***P < 0.001. For gel source data, see 
Supplementary Fig. 1. For n values, see Methods. Scale bar, 1 mm (g, h) 
Extended Data Fig. 7 | Genome-wide identification of Meis1 and Hoxb13 binding sites in 
heart using ChIP–seq. a, Venn diagram showing Meis1 and Hoxb13 binding-site identification. 
Three replicate sequencing runs were performed for each factor, and the enriched regions were 
selected only if they were detected in three biological replicates. b, An example of a Meis1 
binding site in the cell cycle arrest gene Cdkn1b. c, Gene ontology terms enriched in Meis1-, 
Hoxb13- and Meis1–Hoxb13-bound peak regions identified from Extended Data Fig. 7a. 
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Extended Data Fig. 8 | Interaction and dephosphorylation status of Meis1 and Hoxb13 with 
calcineurin. a–c, Coimmunoprecipitation of Fig. 3b–d with negative controls (IgG and DKO 
heart). d, PLA of CnA and Hoxb13 at P7 of DKO heart; serves as negative control for PLA assay 
in Fig. 3e,. e, PLA assay using only one antibody; serves as negative control for the assay. f, 
PLA of CnA and Meis1 in P7 heart showed Meis1–CnA association (red dot). g, h, Schematic 
representation of Meis1 (g, top) and Hoxb13 (h, top) proteins showing the phosphorylatable 
serine and threonine residues, amino acid sequence of Meis1 (g, bottom) and Hoxb13 (h, 
bottom) with potentially phosphorylatable serine and threonine residues in red. Box indicates the 
predicted nuclear localization signal. Numbers indicate amino acid position. i, j, Densitometry 
quantification of western blot analysis in Fig. 3j for Hoxb13 (i) and phosphorylated Hoxb13 
S204 (j). k, Western blot analysis of phosphorylated Meis1 protein at P1 and P7. GAPDH serves 
as loading control. l, Western blot analysis from stable DKO cardiac fibroblasts confirms the loss 
of Hoxb13 in Cre-treated cells. Data are mean ± s.e.m.; unpaired two-sided t-test. Experiments in 
a–f, k–m were repeated independently three times with similar results. *P < 0.05, **P < 0.01, 
***P < 0.001. For gel source data, see Supplementary Fig. 1. For n values, see Methods. Scale 
bars, 10 μm (m), 50 μm (d, e). 
Extended Data Fig. 9 | Increased calcineurin activity suppresses postnatal cardiomyocyte 
proliferation. a, Heart weight/body weight in wild-type, CnA-Tg, Rcan1-Tg, and double-Tg 
mice at P2 (a) and P21 (b). c, d, Representative images of WGA staining for CSA quantification 
in Fig. 3a (c) and Fig. 3c (d). e, f, Representative images of immunostaining for pH3 (green) and 
cardiac troponin T (red) for mitotic cardiomyocytes quantification in Fig. 3b (e) and Fig. 3d (f). 
g, Schematic of apical resection model in P1 mice. Data are mean ± s.e.m.; unpaired two-sided t-
test. *P < 0.05, **P < 0.01, ***P < 0.001. For n values, see Methods. 
Extended Data Table 1 | The sequences of peptides were used to generate phosphor-specific 
Meis1 and Hoxb13 antibodies [Author: Please provide a title for the table]. 
